Molly C. McNamara

BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance

A. Bhutkar, J. Lees, R. Ferretti, 2016, Genes & development.

mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability.

N. Perrimon, D. Kwiatkowski, J. Asara, 2017, Cancer cell.

Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex

D. Kwiatkowski, E. Henske, Chin-Lee Wu, 2022, iScience.

mTORC1 regulates a lysosome-dependent adaptive shift in intracellular lipid species

J. Asara, B. Manning, M. Torrence, 2022, Nature metabolism.

IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.

J. Asara, E. Henske, B. Manning, 2020, JCI insight.

IMPDH inhibitors for anti-tumor therapy in tuberous sclerosis complex

J. Asara, E. Henske, B. Manning, 2019 .